HWL Plans to establish SanQi GAP production base
date：2010-03-29
browse：（436）
Keyword：
Herbridge,29 March 2010-Hutchison Whampoa Guangzhou BaiYunShan Chinese Medicine Company Ltd.(Hutchison Whampoa BaiYunShan for short),a subsidiary of Hutchison Whampoa Ltd. ("HWL"),plans to establish GAP production base for Sanqi.
Hutchison Whampoa BaiYunShan announces the investment of 500 million yuan to build two GAP production base for Sanqi in three years.These bases are located in Yunnan province where the Sanqi output is worth about 97% of the global total volume.
Hutchison Whampoa BaiYunShan has made a compact with Wenshan SanQi Research Institute and Yunnan Hongxiang Yixintang Pharma respectively to cooperate to build GAP production base.Each base is 5000 mu.The establishment of Sanqi base is a part of the GAP strategy of Hutchison Whampoa BaiYunShan,following by isatis root(Fuyang,Anhui province),andrographis paniculata(Qingyuan,Guangdong province),the root of red-rooted salvia(Nanyang,Henan province),serrate rabdosia herb(Taishan,Guangdong).
The two bases will adopt the operational styles:technology+farmers + enterprises.Each base was planted as fllows:the first-year Sanqi,200 mu;the second-year Sanqi,1500 mu;the third-year Sanqi,3500 mu.The total volume is estimated at 1500 tons every year.
However,Hutchison Whampoa BaiYunShan annually used 1000 tons Sanqi."We can't exclude the possibility that we will produce prepared slice to expand product chain."said Li Chuyuan,general manager of Hutchison Whampoa BaiYunShan.
Medicinal herbs are mainly planted by small independent farmers in China.On the one hand,they have no adequate information and capital and thus have no ability to handle the market.On the other hand,they tend to focus on the output rather than quality lured by profits,damaging the reputations unconsciously.Moreover,the complicated process of medicinal herbs circulation provides the opportunity to corner the market.Which is bad for the sustainable development.Li Chuyuan comments:"GAP production bases offer an important means to respond to the raw material market changes for TCM companies."
Hutchison Whampoa BaiYunShan announces the investment of 500 million yuan to build two GAP production base for Sanqi in three years.These bases are located in Yunnan province where the Sanqi output is worth about 97% of the global total volume.
Hutchison Whampoa BaiYunShan has made a compact with Wenshan SanQi Research Institute and Yunnan Hongxiang Yixintang Pharma respectively to cooperate to build GAP production base.Each base is 5000 mu.The establishment of Sanqi base is a part of the GAP strategy of Hutchison Whampoa BaiYunShan,following by isatis root(Fuyang,Anhui province),andrographis paniculata(Qingyuan,Guangdong province),the root of red-rooted salvia(Nanyang,Henan province),serrate rabdosia herb(Taishan,Guangdong).
The two bases will adopt the operational styles:technology+farmers + enterprises.Each base was planted as fllows:the first-year Sanqi,200 mu;the second-year Sanqi,1500 mu;the third-year Sanqi,3500 mu.The total volume is estimated at 1500 tons every year.
However,Hutchison Whampoa BaiYunShan annually used 1000 tons Sanqi."We can't exclude the possibility that we will produce prepared slice to expand product chain."said Li Chuyuan,general manager of Hutchison Whampoa BaiYunShan.
Medicinal herbs are mainly planted by small independent farmers in China.On the one hand,they have no adequate information and capital and thus have no ability to handle the market.On the other hand,they tend to focus on the output rather than quality lured by profits,damaging the reputations unconsciously.Moreover,the complicated process of medicinal herbs circulation provides the opportunity to corner the market.Which is bad for the sustainable development.Li Chuyuan comments:"GAP production bases offer an important means to respond to the raw material market changes for TCM companies."
The latest article
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
